Drug safety should be considered as part of the balance between benefit and risk, and represents a burden to the patient, the healthcare professional, the regulator and industry. Each of these has a different view on adverse drug reactions and these are discussed in this article.
CITATION STYLE
Breckenridge, A. (2015). The burden of adverse drug events. British Journal of Clinical Pharmacology, 80(4), 785–787. https://doi.org/10.1111/bcp.12507
Mendeley helps you to discover research relevant for your work.